This announcement is a separate document:
天津长实律师事务所关于津药药业回购注销股权激励计划已获授但尚未解锁的部分限制性股票及调整回购价格的法律意见书
Legal opinion from Tianjin Changshi Law Firm on Tianjin Tianyao Pharmaceuticals' repurchase and cancellation of stock-based incentive plan, which has been awarded but not yet unlocked, and adjustment of repurchase price.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.